| Literature DB >> 2416835 |
K T Hayglass, S J Naides, C F Scott, B Benacerraf, M S Sy.
Abstract
B cell-deficient, rabbit anti-mouse IgM-treated mice were compared with normal or normal rabbit immunoglobulin-treated controls in their ability to develop proliferative T cell responses, delayed hypersensitivity, and primary or secondary cytotoxic T cell responses. Immunization with hapten-coupled autologous spleen cells resulted in anti-mu-treated mice generating only marginal T cell responses. This decreased responsiveness was shown to be attributable not to an intrinsic T cell defect or to changes in the ability of macrophages from anti-mu-treated mice to present soluble antigen, but rather to the greatly diminished capacity of B cell-deficient spleen cells to present antigen. The results support the concept that B cells play a significant role in antigen presentation required for T cell activation.Entities:
Mesh:
Substances:
Year: 1986 PMID: 2416835
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422